COMPANY

Vascular Biosciences

vascularbiosciences.com ↗ · West Coast

Keywords: diagnostics cardiovascular inflammatory diseases

Profile checked Oct 10, 2026

11NIH grants

NIH awards 11

Annual award amounts. Total $6.5M.

Aug 19, 2022 NIH award 5R42HL151045-03 FY2022: $1,006,870 awarded for that fiscal year; activity R42 (STTR); PI AHSAN, FAKHRUL; recipient as written: VASCULAR BIOSCIENCES, SAN DIEGO, CA. Inhaled Fasudil and DETA NONOate CAR-Targe source ↗
Aug 31, 2021 NIH award 4R42HL151045-02 FY2021: $1,291,298 awarded for that fiscal year; activity R42 (STTR); PI AHSAN, FAKHRUL; recipient as written: VASCULAR BIOSCIENCES, SAN DIEGO, CA. Inhaled Fasudil and DETA NONOate CAR-Targe source ↗
Aug 24, 2020 NIH award 1R42HL151045-01 FY2020: $330,004 awarded for that fiscal year; activity R42 (STTR); PI AHSAN, FAKHRUL; recipient as written: VASCULAR BIOSCIENCES, SAN DIEGO, CA. Inhaled Fasudil and DETA NONOate CAR-Targete source ↗
Aug 11, 2019 NIH award 5R42HL132742-03 FY2019: $746,137 awarded for that fiscal year; activity R42 (STTR); PI YU, PAUL B; recipient as written: VASCULAR BIOSCIENCES, SAN DIEGO, CA. HLS- Cyclic CAR peptide: a targeted therapy for source ↗
Sep 20, 2018 NIH award 4R42HL132742-02 FY2018: $1,255,432 awarded for that fiscal year; activity R42 (STTR); PI YU, PAUL B; recipient as written: VASCULAR BIOSCIENCES, SAN DIEGO, CA. HLS- Cyclic CAR peptide: a targeted therapy fo source ↗
Aug 15, 2017 NIH award 1R42HL132742-01A1 FY2017: $302,402 awarded for that fiscal year; activity R42 (STTR); PI YU, PAUL B; recipient as written: VASCULAR BIOSCIENCES, SAN DIEGO, CA. HLS- Cyclic CAR peptide: a targeted therapy fo source ↗
2016 NIH contract (government contract; not a grant and not an investment round) 268201400006C-3-0-1 FY2016: $385,534 awarded for that fiscal year; activity N01 (OTHER_NIH); PI MANN, DAVID; recipient as written: VASCULAR BIOSCIENCES, SAN DIEGO, CA. IGF::OT::IGF VAS source ↗
2015 NIH contract (government contract; not a grant and not an investment round) 268201400006C-1-0-1 FY2015: $401,635 awarded for that fiscal year; activity N01 (OTHER_NIH); PI MANN, DAVID; recipient as written: VASCULAR BIOSCIENCES, SAN DIEGO, CA. IGF::OT::IGF VAS source ↗
2014 NIH contract (government contract; not a grant and not an investment round) 268201400006C-0-0-1 FY2014: $361,958 awarded for that fiscal year; activity N01 (OTHER_NIH); PI MANN, DAVID; recipient as written: VASCULAR BIOSCIENCES, SAN DIEGO, CA. IGF::OT::IGF VAS source ↗
Jul 21, 2011 NIH award 1R41GM099174-01 FY2011: $220,390 awarded for that fiscal year; activity R41 (STTR); PI RUOSLAHTI, ERKKI; recipient as written: VASCULAR BIOSCIENCES, SAN DIEGO, CA. Injury-targeted decorin for systemic anti- source ↗
Feb 1, 2008 NIH award 1R41HL088771-01A1 FY2008: $165,745 awarded for that fiscal year; activity R41 (STTR); PI KOMATSU, MASANOBU; recipient as written: VASCULAR BIOSCIENCES, SAN DIEGO, CA. Targeting Pulmonary Hypertension with R source ↗